Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Eton Pharmaceuticals (ETON) Other Operating Expenses (2022)

Eton Pharmaceuticals' Other Operating Expenses history spans 2 years, with the latest figure at $1.1 million for Q1 2022.

  • For Q1 2022, Other Operating Expenses changed N/A year-over-year to $1.1 million; the TTM value through Dec 2022 reached $1.1 million, up 1390.67%, while the annual FY2024 figure was -$6.6 million, 308.81% down from the prior year.
  • Other Operating Expenses for Q1 2022 was $1.1 million at Eton Pharmaceuticals, up from $37000.0 in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $1.1 million in Q1 2022 and bottomed at $37000.0 in Q4 2021.